Escorial, Elvie .
HRN: 23-51-97 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/09/2023
METRONIDAZOLE 500MG (TAB)
08/09/2023
08/16/2023
PO
500 Mg
TID
TMSAF
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes